| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 150 |
| 1 | METHOTREXATE SODIUM | 146 |
| 2 | ETANERCEPT | 139 |
| 3 | SULFASALAZINE | 138 |
| 4 | ABATACEPT | 136 |
| 5 | LEFLUNOMIDE | 136 |
| 6 | TOCILIZUMAB | 135 |
| 7 | METHOTREXATE | 130 |
| 8 | INFLIXIMAB | 129 |
| 9 | RITUXIMAB | 124 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSTEMSAVIR TROMETHAMINE | 1 | 0.0041 |
| 1 | NITROUS OXIDE | 8 | 0.0036 |
| 2 | DICLOFENAC POTASSIUM | 28 | 0.0025 |
| 3 | CALCIUM GLUCONATE | 28 | 0.0023 |
| 4 | ETRAVIRINE | 10 | 0.0023 |
| 5 | CORTISONE ACETATE | 28 | 0.0022 |
| 6 | GOLIMUMAB | 27 | 0.0021 |
| 7 | ADALIMUMAB-FKJP | 86 | 0.0019 |
| 8 | SULFASALAZINE | 138 | 0.0019 |
| 9 | ADALIMUMAB-AATY | 86 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 143 |
| 1 | Aminosalicylate [EPC] | 138 |
| 2 | Antirheumatic Agent [EPC] | 137 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 136 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 135 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 130 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 124 |
| 7 | Corticosteroid [EPC] | 52 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 9 | Vitamin B12 [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aminosalicylate [EPC] | 138 | 0.0014 |
| 1 | Antirheumatic Agent [EPC] | 137 | 0.0013 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 135 | 0.0010 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 136 | 0.0010 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0006 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 6 | 0.0004 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 124 | 0.0004 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 130 | 0.0003 |
| 8 | Protease Inhibitor [EPC] | 11 | 0.0002 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 30 | 0.0002 |